The company is one of the first to launch a generic version of the discontinued Abilify Oral Solution used to treat depression, bipolar disorder and schizophrenia.
The Food and Drug Administration announced approval for the first generic versions of aripiprazole tablets.
The Food and Drug Administration has approved a once-monthly treatment for schizophrenia.
A generic version of a schizophrenia drug made by Otsuka Holdings and Bristol-Myers Squibb can't be launched until April 2015, according to published reports.
The Food and Drug Administration has approved a psychiatric drug for treating bipolar disorder when used in combination with one of two other drugs.